Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Total Assets

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF (GERM) currently reports a total assets of $16B as of June 2026. That compares with $10B in the prior-year period — up 54.5% year over year. Use the charts on this page to explore Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's total assets history and peer comparisons.

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's total assets increased from $10B to $16B — a 54.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF reported $16B in total assets as of June 2026. That compares with $10B in the prior-year period — up 54.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $16B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF, and consider following GERM for alerts when major investors trade the stock.